logo

For the Inventor, By the Inventor

Surrey, United Kingdom

Florence Irene Raynaud

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cancer Research Technology Limited, Cyclacel Limited. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florence Irene Raynaud. Retrieved from https://idiyas.com/inventor/florence-irene-raynaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 42.9



Average Co-Inventor Count = 8.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Surrey, GB (2006 - 2010)
  • London, GB (2009 - 2014)

Company Filing History:

goldMedal7 out of 268 
 
Cancer Research Technology Limited
 patents
silverMedal4 out of 56 
 
Cyclacel Limited
 patents
where one patent can have more than one assignee

Years Active: 2006-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8846696 - Purine derivatives (2014-09-30),
2. 7674823 - DNA-PK inhibitors (2010-03-09),
3. 7612079 - 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders (2009-11-03),
4. 7582642 - Purine derivatives (2009-09-01),
5. 7544689 - Purine derivatives (2009-06-09),
6. 7226918 - DNA-PK inhibitors (2007-06-05),
7. 7105518 - Thiopyrane-4-ones as DNA protein kinase inhibitors (2006-09-12),

Title: Florence Irene Raynaud: Innovator in Pharmaceutical Chemistry

Introduction

Florence Irene Raynaud is a distinguished inventor based in Surrey, GB. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. Her work primarily focuses on developing innovative compounds for treating various medical conditions.

Latest Patents

Among her latest patents, Raynaud has developed purine derivatives that relate to compounds designed for treating proliferative disorders, viral disorders, stroke, alopecia, CNS disorders, neurodegenerative disorders, and diabetes. Additionally, she has worked on DNA-PK inhibitors, which are used in the preparation of medicaments aimed at inhibiting the activity of DNA-PK. These compounds selectively inhibit DNA-PK compared to PI 3-kinase and/or ATM, showcasing her innovative approach to drug development.

Career Highlights

Raynaud has worked with notable companies such as Cancer Research Technology Limited and Cyclacel Limited. Her career reflects a commitment to advancing medical science through her inventive work.

Collaborations

Throughout her career, Raynaud has collaborated with esteemed colleagues, including Bernard Paul Nutley and Paul Workman. These partnerships have further enriched her contributions to the field.

Conclusion

Florence Irene Raynaud's innovative work in pharmaceutical chemistry has led to significant advancements in medical treatments. Her patents and collaborations highlight her dedication to improving healthcare through scientific innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…